Biochips Market Size

Biochips Market size was valued at USD 10.44 billion in 2024 and is expected to cross USD 60.13 billion by the end of 2037, expanding at more than 14.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of biochips is estimated at USD 11.64 billion. The growth of the market can be attributed to the increasing occurrence of immunodeficiency disorders among people throughout the world. For instance, more than 7 million persons worldwide were suffering from primary immunodeficiencies by 2021, with around 75 to 93% remaining untreated. Further, there are around 430 different primary immunodeficiencies or primary immunodeficiency disorders (PIDs) that have been discovered to date. Further, the rapidly rising adoption of biochips in various research fields, such as genomics, drug discovery, proteomics, and so on is also estimated to fuel the market growth of the global biochips market throughout the forecast period.

In addition to these, factors that are believed to fuel the market growth of biochips include the rise in the need to develop novel vaccines through extensive medical research, backed by amplified funding in medical R&D activities across the globe. For instance, in 2019, the pharmaceutical industry in the United States invested more than USD 85 billion in research and development activities. These costs covered a wide range of operations, including medication research and testing, incremental enhancements including product expansions, and medical studies for safety monitoring. Additionally, increasing advances in the Lab-on-a-chip offerings along with the biomedical progression for microfluidic-based devices are also predicted to present the potential for market expansion over the projected period.